Articles From: National Water Conservation Tour Readies Mayors for Earth Month Challenge to Organizations Make Strides in Adoption of Analytics, but Struggle to Capitalize on Investments, Accenture Research Finds


2013/3/5
U.S. Cities Gear Up to Compete in Water-Wise Challenge during April TORRANCE, Calif.
Sign-up for National Water Conservation Tour Readies Mayors for Earth Month Challenge investment picks
2013/3/5
-- Revenues Increased 22.2% to $298 Million -- --
Sign-up for NCI Building Systems Reports First Quarter Fiscal 2013 Results investment picks
2013/3/5
Neonode Inc ., (NASDAQ:NEON) , the optical touch technology company, today announced that its Senior VP of Corporate Finance and Investor Relations, Daniel Gelbtuch, is scheduled to present at the Wedbush 2013 Transformational Technology Conference at the Le Parker Meridien Hotel in New York City on March 6th and 7th.
Sign-up for Neonode® to Present at the Wedbush 2013 Transformational Technology Conference investment picks
2013/3/5
http://media.marketwire.com/attachments/201211/98749_netapp.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=992885&ProfileId=051205&sourceType=1 SUNNYVALE, CA --
Sign-up for NetApp Enables Revlon to Simplify IT Operations With Transition to an Agile Data Infrastructure investment picks
2013/3/5
NetScout Systems, Inc. announced today that it will be presenting at the Wedbush 2013 Transformational Technology Management Access Conference at the Le Parker Meridien Hotel, New York, NY.
Sign-up for NetScout Systems to Present at the Wedbush 2013 Transformational Technology Management Access Conference investment picks
2013/3/5
Reinforcing its commitment to environmental sustainability, District of Columbia Department of General Services (DGS) has signed a one-year contract for 100 percent WGES CleanSteps® WindPower from Herndon-based Washington Gas Energy Services ( WGES ). This new contract stipulates that Washington, D.C. government agencies will use 100 percent wind power for their electricity needs.
Sign-up for New Contract with Washington Gas Energy Services Helps City Retain Position as the Nation’s #1 Green Power Community investment picks
2013/3/5
SAN FRANCISCO (MarketWatch) — It took more than five years, but the Dow Jones Industrial Average finally closed at a record high after hitting a new intraday high just after the open.
Sign-up for New Dow high: Rally point or new ceiling? investment picks
2013/3/5
New feature works with models built using most leading modeling tools SAN JOSE, Calif.
Sign-up for New Rapid-Deployment Capability in FICO Model Central Slashes Time-to-Value of Predictive Models by Up to 80 Percent investment picks
2013/3/5
NEW YORK, March 5, 2013 (GLOBE NEWSWIRE) -- New York Mortgage Trust, Inc. (Nasdaq:NYMT) ("NYMT" or the "Company") today reported results for the three and twelve months ended December 31, 2012.
Sign-up for New York Mortgage Trust Reports Fourth Quarter and Full Year 2012 Results investment picks
2013/3/5
Nordion Inc. (TSX: NDN) (NYSE: NDZ) , a leading provider of products and services for the prevention, diagnosis and treatment of disease, announced today that it has launched a new and improved, intuitive, feature-rich TheraSphere® website, providing liver cancer patients and physicians with customized TheraSphere® resources that include medical and clinical information, convenient online ordering, and innovative digital resources.
Sign-up for Nordion Launches a New and Improved TheraSphere® Website to Meet the Needs of Liver Cancer Physicians, Patients and Caregivers Worldwide investment picks
2013/3/5
Nordion Inc. (TSX: NDN) (NYSE: NDZ: Revenue of $53.7 million in Q1 2013, an increase of 1% over Q1 2012 Adjusted earnings per share, excluding specified items, decreased to $0.07 in Q1 2013, down from adjusted earnings per share of $0.11 in the first quarter fiscal 2012 TheraSphere revenue of $12.0 million in Q1 2013, an increase of 9% over Q1 2012 Nordion reports in U.S. dollars unless otherwise specified Nordion Inc. (TSX: NDN) (NYSE: NDZ) , a leading provider of products and services to the global health science market, today reported results for the first quarter of fiscal 2013.
Sign-up for Nordion Reports First Quarter Fiscal 2013 Financial Results investment picks
2013/3/5
Company to Webcast Conference Call at 10:00 a.m. ET on March 15 PROVIDENCE, R.I. , March 5, 2013 /PRNewswire/ -- Nortek, Inc. (Nasdaq: NTK) , a global diversified manufacturer of innovative, technology-driven products and solutions for residential and commercial applications, today announced that it will release its fourth-quarter and year-end 2012 financial results after the close of the market on Thursday, March 14, 2013 .
Sign-up for Nortek to Announce Fourth-Quarter 2012 Financial Results on March 14 investment picks
2013/3/5
NPS Pharmaceuticals, Inc. (NASDAQ: NPSP) will present at the Barclays Capital Global Healthcare Conference in Miami, Florida on Wednesday, March 13, 2013 at 11:15 a.m. ET.
Sign-up for NPS Pharmaceuticals to Present at Barclays Capital Global Healthcare Conference investment picks
2013/3/5
NRG Energy, Inc. (NYSE: NRG) , through its wholly owned subsidiary NRG Solar, announced the start of commercial operations for the Borrego I Solar Generating Station, a 26 megawatt (AC) photovoltaic facility located northeast of Borrego Springs, Calif.
Sign-up for NRG Begins Operations at 26 MW Borrego Solar Photovoltaic Facility investment picks
2013/3/5
Nuance Communications, Inc. (NASDAQ: NUAN) today announced significant expansions to Nina TM , the virtual assistant for customer service.
Sign-up for Nuance Expands Nina, the Virtual Assistant for Customer Service, to the Web and Beyond investment picks
2013/3/5
Nutrisystem, Inc. (NASDAQ: NTRI) , a leading provider of weight management products and services, today reported financial results for the year ended December 31, 2012.
Sign-up for Nutrisystem Reports 2012 Results investment picks
2013/3/5
Nuvo Research announces FDA response to PENNSAID® 2% NDA Canada NewsWire MISSISSAUGA, ON, March 5, 2013 /CNW/ - Nuvo Research Inc. (Nuvo) (TSX:NRI) announced today that its U.S. licensing partner, Mallinckrodt, the Pharmaceuticals Business of Covidien (NYSE:COV) , has received a Complete Response Letter (CRL) from the U.S. Food and Drug Administration (FDA) following the review of Mallinckrodt's New Drug Application (NDA) for diclofenac sodium topical solution, 2% w/w (PENNSAID 2%). In the letter, the FDA requires that Mallinckrodt successfully complete a pharmacokinetic study comparing PENNSAID 2% to original PENNSAID 1.5%. Similar pharmacokinetic studies submitted by Mallinckrodt with the NDA were not acceptable to the FDA because reserve samples were not retained at the clinical site.
Sign-up for Nuvo Research announces FDA response to PENNSAID® 2% NDA investment picks
2013/3/5
MISSISSAUGA, ON , March 5, 2013 /PRNewswire/ - Nuvo Research Inc. (Nuvo) (TSX:NRI) announced today that its U.S. licensing partner, Mallinckrodt , the Pharmaceuticals Business of Covidien (NYSE:COV) , has received a Complete Response Letter (CRL) from the U.S. Food and Drug Administration (FDA) following the review of Mallinckrodt's New Drug Application (NDA) for diclofenac sodium topical solution, 2% w/w (PENNSAID 2%). In the letter, the FDA requires that Mallinckrodt successfully complete a pharmacokinetic study comparing PENNSAID 2% to original PENNSAID 1.5%. Similar pharmacokinetic studies submitted by Mallinckrodt with the NDA were not acceptable to the FDA because reserve samples were not retained at the clinical site.
Sign-up for Nuvo Research announces FDA response to PENNSAID® 2% NDA investment picks
2013/3/5
http://media.marketwire.com/attachments/201303/TN-133564_Quadro-K4000.jpg A high-end card that delivers blazing-fast performance for graphics-intensive applications, the NVIDIA Quadro K4000 -- built on the ultra-efficient NVIDIA Kepler architecture --
Sign-up for NVIDIA Sets New Standard for Workstation Performance and Reliability investment picks
2013/3/5
http://media.marketwire.com/attachments/201004/5033_nxp-one.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=993393&ProfileId=051205&sourceType=1 EINDHOVEN, THE NETHERLANDS --
Sign-up for NXP Announces Upsizing and Pricing of Senior Unsecured Notes Offering investment picks
2013/3/5
HASBROUCK HEIGHTS, N.J., March 5, 2013 (GLOBE NEWSWIRE) -- Nymox Pharmaceutical Corporation (Nasdaq:NYMX) today provided an update on U.S. Phase 2 prostate cancer clinical trial activities for NX-1207, the company's new investigational drug being tested for early stage prostate cancer.
Sign-up for Nymox Provides Current Phase 2 Prostate Cancer Clinical Trial Update investment picks
2013/3/5
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=11G003836-001&sourceType=1 http://www.marketwire.com/library/MwGo/2013/3/2/11G003836/Logo1-457731497.jpg HANNOVER, GERMANY --(Marketwire - March 05, 2013) - CeBIT 2013 --
Sign-up for OCZ Technology Launches New VXL 1.3 Software at CeBIT 2013, Evolving Solid State Virtualization and Caching to New Levels investment picks
2013/3/5
HOUSTON , March 5, 2013 /PRNewswire/ -- Omega Protein Corporation (NYSE:OME) today reported financial results for the fourth quarter and full year ended December 31, 2012 .
Sign-up for Omega Protein Announces Fourth Quarter and Full Year 2012 Financial Results investment picks
2013/3/5
ON Semiconductor (Nasdaq: ONNN ), driving energy efficient innovations, has introduced a new family of Tunable RF Components (TRFC) that address the design challenges faced by engineers developing the latest generation smartphones.
Sign-up for ON Semiconductor Launches Tunable RF Components for Smaller, Thinner Smartphones with Reliable Antenna Performance investment picks
2013/3/5
AT&T Unified Communications Connects Today's Mobile Worker With the Click of a Button LONDON , March 5, 2013 /PRNewswire/ -- Technology continues to bring the global business community closer together, enabling employees to collaborate effectively without having to be in the same office space – or even the same country.
Sign-up for On-The-Go Collaboration Made Easy For Global Businesses investment picks
2013/3/5
Oncolytics Biotech® Inc. Completes Patient Enrollment in U.S. Phase 2 Study of REOLYSIN® in Non-Small Cell Lung Cancer Canada NewsWire About Oncolytics Biotech Inc. Oncolytics is a Calgary-based biotechnology company focused on the development of oncolytic viruses as potential cancer therapeutics.
Sign-up for Oncolytics Biotech® Inc. Completes Patient Enrollment in U.S. Phase 2 Study of REOLYSIN® in Non-Small Cell Lung Cancer investment picks
2013/3/5
CALGARY , March 5, 2013 /PRNewswire/ - Oncolytics Biotech Inc. ("Oncolytics") (TSX:ONC) (NASDAQ:ONCY) today announced that it has completed patient enrollment in a Phase 2 clinical trial evaluating intravenous administration of REOLYSIN ® in combination with paclitaxel and carboplatin in patients with non-small cell lung cancer (NSCLC) with Kras or EGFR-activated tumours (REO 016). This trial is a single arm, single-stage, open-label, Phase 2 study of REOLYSIN given intravenously with paclitaxel and carboplatin every three weeks.
Sign-up for Oncolytics Biotech® Inc. Completes Patient Enrollment in U.S. Phase 2 Study of REOLYSIN® in Non-Small Cell Lung Cancer investment picks
2013/3/5
http://media.marketwire.com/attachments/200906/438886_oracleresized.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=992795&ProfileId=051205&sourceType=1 REDWOOD SHORES, CA --
Sign-up for Oracle Introduces the Oracle Database Appliance X3-2 investment picks
2013/3/5
Combined Technology from Stanley Healthcare and CareFusion Creates Solution for Near Real-Time Location and Utilization Data of IV Pumps NEW ORLEANS , March 5, 2013 /PRNewswire/ -- Oregon Health & Science University received an award last night from the RFID in Healthcare Consortium/Intelligent Hospital for the "2013 Best Comprehensive Integration" of advanced health care technology.
Sign-up for Oregon Health & Science University Receives Award For Leadership In Advanced Healthcare Technology Solutions investment picks
2013/3/5
Organizations are progressing in the adoption of analytics for decision making, according to new research from Accenture (NYSE: ACN) .
Sign-up for Organizations Make Strides in Adoption of Analytics, but Struggle to Capitalize on Investments, Accenture Research Finds investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Morningstar Investing Classroom Rewards (earn as you learn and redeem for Morningstar merchandise)
P   Morningstar Fund Analyst Reports (full research on 2,000 funds and ETFs)
P   Morningstar Stock Analyst Reports (full research on 2,000 stocks)
P   Morningstar Stock and Fund Stewardship Grades
P   Portfolio Manager (advanced with 10 x-ray analyses, including guidance)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Articles From: National Water Conservation Tour Readies Mayors for Earth Month Challenge to Organizations Make Strides in Adoption of Analytics, but Struggle to Capitalize on Investments, Accenture Research Finds
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity